Researchers track rare disease to unlock clues for future therapies

NCT ID NCT03173300

First seen Nov 18, 2025 · Last updated Apr 23, 2026 · Updated 21 times

Summary

This study is for people with PMM2-CDG, a rare genetic disorder. Researchers will collect medical information and test results from 120 participants over time. The goal is to learn more about how the disease progresses, which can help design better treatments in the future. No experimental drugs are given—this is an observational study only.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHOSPHOMANNOMUTASE 2 DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Centro Hospitalar do Porto

    Porto, Portugal

  • Children's Hospital of Philadelphia (CHOP)

    Philadelphia, Pennsylvania, 19104, United States

  • General University Hospital in Prague

    Prague, Czechia

  • Hospital Sant Joan de Déu

    Barcelona, Spain

  • Mayo Clinic College of Medicine

    Rochester, Minnesota, 55905, United States

  • Mother and Child Institute (Instytut Matki i Dziecka)

    Warsaw, Poland

  • Necker Enfants-Malades Hospital

    Paris, France

  • Radboud University Nejmegen Medical Center

    Nijmegen, Netherlands

  • Seattle Children's Hospital

    Seattle, Washington, 98105, United States

  • University Hospital Leuven

    Leuven, Belgium, Belgium

  • University Hospital of Catania

    Catania, Italy

Conditions

Explore the condition pages connected to this study.